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Measurement of health-related quality of life (HRQoL) is important for a chronic disease,
such as dementia, which impairs the quality of life of affected patients in addition to their
length of life. This is important in the context of economic evaluations when interventions do
not (only) affect HRQoL and these other factors also affect overall quality of life.
Objective
To validate the Spanish translation of the ICECAP-O’s capability to measure Health-related
quality of life in elderly with dementia who live in nursing homes.
Method
Cross-sectional study. For 217 residents living in 8 Spanish nursing homes, questionnaires
were completed by nursing professionals serving as proxy respondents. We analyzed the
internal consistency and other psychometric properties. We investigated the convergent
validity of the ICECAP-O with other HRQoL instruments, the EQ-5D extended with a cogni-
tive dimension (EQ-5D+C), the Alzheimer’s Disease Related Quality of Life (ADRQL) mea-
sures, and the Barthel Index measure of activities of daily living (ADL).
Results
The ICECAP-O presents satisfactory internal consistency (alpha 0.820). The factorial analy-
sis indicated a structure of five principal dimensions that explain 66.57% of the total vari-
ance. Convergent validity between the ICECAP-O, EQ-5D+C, ADRQL, and Barthel Index
scores was moderate to good (with correlations of 0.62, 0.61, and 0.68, respectively), but
differed between dimensions of the instruments. Discriminant validity was confirmed by find-
ing differences in ICECAP-O scores between subgroups based on ADL scores (0.70 low,
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0.59 medium, and 0.39 high level care), dementia severity (0.72 mild, 0.63 medium, and
0.50 severe), and ages (0.59 below 75 years and 0.84 above 75 years).
Conclusions
This study presented the first use of a Spanish version of the ICECAP-O. The results indi-
cate that the ICECAP-O appears to be a reliable Health-related quality of life measurement
instrument showing good convergent and discriminant validity for people with dementia.
Introduction
Population aging is a phenomenon of social importance caused by reduced mortality, birth
control, and increased life expectancy [1]. In Spain, this aging process has occurred more rap-
idly than global averages; the population over 65 years old increased from 14.95% in 1995 to
18.4% in 2016, and life expectancy, at 83.3 years, is among the highest in the European Union
[2].
This has given way to increased degenerative diseases, including dementia. The changes
that occur in dementia include a loss of function that makes the affected more dependent on
others for the performance of activities [3] [4]. These types of diseases alter the quality of life of
affected individuals due to the changes that occur at the physical, social, psychological, and
even spiritual levels [3]. In the latest study in Spain the estimated prevalence of dementia in
individuals aged 65 and older in Madrid, was 61.7% (confidence interval [CI] 95%, from 58.4
to 65.1). Alzheimer’s disease was presented with a prevalence of 16.9% (95% CI, 14.3 to 19.5)
[5].
Frequently, in advanced stages of dementia, a sufficient amount and quality of professional
care can only be provided in an institutional long-term care setting, making admissions inevi-
table for a growing number of elderly with dementia [6]. Two-thirds of older people living in
nursing homes in Spain have dementia [7]. Faced with increasing demand, the long-term care
sector in many countries may experience strong budgetary pressures and increased questions
about optimal resource allocation and affordability of care [8].
Dementia has substantive effects on healthy aging as it can negatively impact one’s health-
related quality of life (HRQoL) [9]. Health-related quality of life has been defined as an indi-
vidual’s subjective experience of the impact that illnesses and their treatments have on the indi-
vidual’s functioning in a variety of domains, such as physical, psychological and social
functioning, as well as the impact of illnesses on the ability to engage in daily activities [9].
Broader HrQoL measures, often named wellbeing measures, should be used to capture more
facets of peoples’ lives than health status alone. In the context of providing long-term care for
those with dementia, HRQoL is important outcomes to assess and monitor [10]. In fact,
HRQoL is identified as an important outcome in interventions aimed at combatting cognitive
dysfunction [11]. In dementia, determining HRQoL is limited by cognitive disorders and
incorporates external elements in relation to the activities and remaining positive behaviors
[12]. Evaluating HRQoL in dementia is feasible in other disorders with similar effects,
although in advanced stages of dementia the patient self-assessment is replaced by a reliable
informant. HRQoL is a measure used for various reasons, such as to measure the impact of
care and treatment received, the quality of care, the evolution of the disease itself, and the eco-
nomic impact [13] [14] [15]. In economic evaluations, benefits are frequently assessed by
changes in HRQoL combined with the duration an individual spends in various health states.
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Economic evaluation is increasingly used in in the health sector as a decision support tool
for resource allocation, but may aid the allocation of resources in long-term care as well [16]
[17].
HRQoL is most commonly measured with the EQ-5D instrument [18]; however, Euro
Quality of Life 5D (EQ-5D) is a very generic measurement instrument that only takes HRQoL
into account and is therefore not sufficient for a complete economic evaluation in the case of
patients with dementia [17]. Other more specifics instruments, such as Alzheimer Disease-
related Quality of Life (ADRQL) [19] [20], include further aspects of a patient’s life but do not
take into account physical health and do not allow for comparison across different diseases
[17] [21]. This is of particular relevance to the nursing home population, where older people
typically suffer from a range of co-morbidities [21], making it difficult to perform a complete
assessment of the impact of specific interventions using disease-specific HRQoL instruments
alone.
The most widely applied older-person specific instrument to measure quality of life is the
ICECAP-O (Investigating Choice Experiments for the Preferences of Older People) [22, 23], a
relatively new developmental instrument [24]. ICECAP-O seems to satisfy the requirements of
economic evaluation in the case of dementia [22] [23]. It is intended as an outcome that mea-
sures economic evaluations of both health and social services, where beyond health, wellbeing
aspects also have to be considered. ICECAP-O is an instrument with a broader perspective
than HRQoL and is conceptually based on the capability approach [25]. It was originally devel-
oped in the UK for use in the economic evaluation of health and social care interventions [22]
and to cover the domains of attachment (love and friendship), security (thinking about the
future without concern), role (doing things that make you valued), enjoyment (pleasure), and
control (independence). Validation studies confirmed that the ICECAP-O evaluates a spec-
trum of outcomes beyond HRQoL [26]. Until now, the ICECAP-O was used in the general
population in the UK [22] and Australia [27], in a psychogeriatric nursing home setting in the
Netherlands [28], in Dutch psycho-geriatric nursing homes [29], in nursing home residents
with dementia in German [30], in a population of post-hospitalized older adults in the Nether-
lands [31], and among older adults with mobility impairments in Canada [32]. After carrying
out a systematic review and contacting the original authors of the instrument [22, 23], to date,
the ICECAP-O has not been validated in a population of patients with dementia in nursing
homes in Spain.
The aim of this study to validate the Spanish translation of the ICECAP-O’s capability to
measure Health-related quality of life in elderly with dementia who live in nursing homes.
Methods
Design, Setting, Study Population, and Data Collection
A cross-sectional study was conducted in 8 nursing homes belonging to the same foundation
spread over 6 cities in Spain. They involved 217 people with dementia in moderate stages who
were older than 65 and had been living in the nursing home for longer than 3 months. Four-
teen nursing professionals of each nursing home were asked to complete the questionnaire in
the manner that the patient would have if he/she were able to answer the questions. In all the
cases, five researchers collected all the data, interviewing all patients and the collaborating
nurses when needed.
Inclusion criteria: over 65 years of age and institutionalized for more than 3 months, pre-
senting a diagnosis of dementia with over six months of evolution, classified according to the
GDS (inclusion levels 4 to 6 of the Global Deterioration Scale (GDS) [33]. This classification
should be made by the neurologist who diagnosed or followed the evolution of the patients.
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The study was approved by the Bioethics Committee of the Foundation in Madrid (COD.
2016.08) and at all directions of the centers. Informed consent was obtained from legal guard-
ians for all participants after they were informed verbally and in writing. The principal investi-
gator is responsible for keeping informed consent.
Sample size. The sample size was estimated with a programme for calculating sample size
and the power of a contrast of hypothesis (Granmo v. 7.11, developed by Institut Municipal
d’Investigació Mèdica, Barcelona, Spain), for a significance level of 0.05 and a power of 0.8,
assuming equal variances). Adjusting for a dropout rate of 20%, it was determined that 208
people were needed.
Instruments
Different socio-demographic variables of patients were collected, such as age, sex, marital sta-
tus, and length of stay in the nursing home.
The Global Deterioration Scale (GDS) [33] assesses the degree of dementia. This scale
enables the evolution of cognitive impairment from normal aging to a person with dementia.
It consists of seven phases, ranging from "zero cognitive impairment" to "very severe demen-
tia." The first two levels (GDS 1 and 2) correspond to normal states. The GDS 3 is the first
phase in which there are clear deficits, although it is not considered sufficient to diagnose
dementia. GDS 4, GDS 5, GDS 6, and GDS 7 reflect a cognitive impairment linked to dementia
(mild, moderate, and severe dementia, respectively).
The ICECAP-O [22] [23] measures capability wellbeing using five domains or attributes
(attachment, security, role, enjoyment, and control), with one question per dimension. Distin-
guishing four levels within each domain (levels generally range from all, a lot, a little, to not
any; exact wording of levels varies per dimension). Each level distinguishes 1,024 possible
“capability states.” The ICECAP-O tariffs have values between 0 (no capabilities) and 1 (full
capabilities). The ICECAP-O is a five-item multiple choice questionnaire where each attribute
has 4 possible response options. For this first use of the ICECAP-O in Spanish, the instru-
ments’ original author’s/recommended translation guidelines were fully met. The original
ICECAP-O version, as developed by Coast et al., [23] was forward-backward translated from
English into Spanish by two independent translators. Subsequently it was translated back into
English by two independent translators. The last version in English was sent to the original
authors of the application for its validation.
In order to compute capability values, the British tariffs were applied because these do not
exist for Spain. Lower scores thus represented fewer preference-based capabilities. The com-
plete explanation as to how to calculate them was fully described on the ICECAP website:
http://www.icecap.bham.ac.uk/tariffs.shtml.
Alzheimer Disease Related Quality of Life (ADRQL) [19]. We used the revised 40-item
version that allows for the assessment of QoL for people with mild, intermediate, or late-stage
dementia using proxy responses [34]. The dementia-specific, multi-dimensional ADRQL
instrument can be completed by patients’ professional caregivers [20]. The ADRQL measures
the dimensions of social interaction, awareness of self, enjoyment of activities, feelings and
mood, and response to surrounding. The various dimensions range from 4 to 12 items on a
dichotomous scale and each item is weighted in a range between 9.15 and 13.75, based on a
judgment of importance by caregivers [20]. For each dimension, a separate subscale can be cal-
culated and summed up in one total score ranging from 0 (lowest quality of life) to 100 (high-
est quality of life) [19]. The instrument exhibits good psychometric properties with adequate
validity, good internal-consistency reliability, very low missing data, and good sensitivity to
change [20] [34].
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The EQ5D [18] Spanish version [35] measures HRQoL in terms of five dimensions (mobil-
ity, self-care, daily activities, pain and discomfort, and anxiety and depression) with three levels
each (1 = no problems, 2 = moderate problems, and 3 = extreme problems) describing 243
health states. For use in people with dementia, the EQ-5D was extended with a cognitive
dimension (EQ-5D+C), for which utility scores are unavailable [35] [36]. The health index
component of the EQ-5D+C is therefore made up of six dimensions: mobility, self-care, usual
activities, pain/discomfort, anxiety/depression, and cognition. Each dimension has three levels:
no problems, some problems, and extreme problems.
The Barthel-Index [37], Spanish version [38] has 10 items of activities of daily living
(ADL): feeding, grooming, bathing, dressing, bowel and bladder care, toilet use, ambulation,
transfers, and stair climbing. The total score ranges from 0 to 10. The total score thus ranges
between 0 (completely dependent) and 100 (completely independent) with a cutoff score of 65
indicating need for ADL assistance, with a classification in low (40–65), medium (20–40), and
high (<20) care dependency groups. This is the most common test that measures residents’
abilities to perform activities of daily living by proxy- or self-report.
Hypotheses
To establish convergent validity we expected moderate to strong and positive correlations
between the ICECAP-O, the EQ-5D+C, and ADRQL (these instruments measure partial oper-
ationalizations of QoL) (H1). Furthermore, we expected a moderate and positive correlation
between the ICECAP-O dimension and tariff scores and the Barthel Index (ADL) (H2). For
discriminant validity, we expected to find differences in ICECAP-O tariff scores between resi-
dents suffering from severe, moderate, and mild/moderate dementia (based on the GDS),
between ADL dependent (Barthel score <65) and ADL independent (Barthel score >65) resi-
dents between low, medium, and high care dependency groups (H3). A higher score on the
ICECAP-O was expected for the better-off groups.
Data Analysis
The construct validity of the ICECAP-O questionnaire was calculated through factor analysis
using principal component extraction and Varimax rotation with Kaiser. Each variable was
included in a single factor, according to their factor loading, by setting minimum saturation
criteria of 0.50. Varimax rotation is assumed to be the most appropriate, since it is expected to
discriminate between the maximum number of factors forming the scale. Estimates of sam-
pling adequacy for Kaiser-Meyer-Olkin (KMO; range 0–1) and Barlett statistical significance
(if its value is close to the unit and they are significant with p<0.05, indicating that the analysis
with reduced variables is appropriate) were calculated. The reliability of the questionnaire was
calculated by analyzing the internal consistency, using Cronbach Alpha, which should be
interpreted as an indicator of the internal consistency of the items, because it is calculated
from the covariance between them.
The demographic characteristics of residents and proxies were analyzed using descriptive
statistics. Mean or median, standard deviation, were computed from the demographic data of
the residents and for the different dimensions of the instruments. Correlations between the
outcomes of the ICECAP-O and dimensions of the ADRQL, EQ-5D+C, and ADL were used
to estimate convergent validity. Discriminant validity was analyzed using a t-test and one-way
ANOVA to explore differences in means of the ICECAP-O between different demographic
and dementia-related groups. For all analyses the level of significance was set at p<0.05. Data
was analyzed using SPSS v.22.0.
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Results
Reliability Analysis and Questionnaire Validity
Estimates of sampling adequacy of Kaiser-Meyer-Olkin (KMO = 0.877) and Bartlett statistical
significance (p = 0.000) were calculated. Communalities analysis indicated that all items
are above 0.5, and then all questions were accepted as valid to form part of the questionnaire.
Using this method, the principal components’ 5 major components or the factors with eigen-
values greater than 1 were obtained, which account for 66.57% of the total variance, and an
explanation percentage at appropriate acceptance levels was obtained (see Table 1).
These factors were classified as the same 5 domains or attributes as the original version
[21]: attachment, security, role, enjoyment, and control. One item was included in a single fac-
tor, according to their factor loading, by setting saturation minimum criteria at 0.30. Rotated
factor solutions according to VARIMAX formed a well-defined structure without overlapping.
To assess the internal consistency of the questionnaire a Cronbach alpha value of 0.820 was
obtained. This value was not improved by eliminating some of the items, therefore all items
were maintained. The values of item-total correlation ranged between 0.52 and 0.73.
Demographics and Descriptive Characteristics
Data were collected between March and June 2016. The questionnaires were collected in 8
nursing homes by 14 nurses from a total of 217 patients with mid-stage dementia. Table 2
shows the sociodemographic variables, the characteristics of the residents, the measurement
instruments, and their dimensions.
Convergent Validity
Table 3 shows that the ICECAP-O scores were strongly correlated with EQ-5DC scores,
ADRQL scores, and Barthel scores. Correlations between the ICECAP-O tariff scores and the
different dimensions of the EQ-5D+C were strong and significant. Correlations between the
ICECAP-O and the ADRQL proved to be similarly strong and significant.
The individual ICECAP-O dimensions of role and control were strongly and significantly
correlated with the EQ-5D+C and to a lesser extent with dimension mobility and self-care,
usual activities, pain/discomfort, and cognition. Attachment was significantly and strongly
correlated with SI, FM, and EA (ADRQL). The Barthel index was significantly correlated with
all ICECAP-O dimensions with correlations between the Barthel index and the role and con-
trol dimensions being particularly strong.
Table 1. Total variance explained.
Component Rotation sums of squared loadings
Total % of variance % cumulative
1 5.48 21.21 21.21
2 2.26 14.78 36.00
3 2.10 12.47 48.47
4 1.91 9.54 58.02
5 1.84 8.54 66.57
doi:10.1371/journal.pone.0169354.t001
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• Mild (4) 10.2%
• Moderate (5) 32.6%
• Severe (6/7) 57.2%
Months living in nursing home
• 3 6 months 3.7%
• 6 12 months 7.5%
• 12 24 months %







• Attachment (0.62) 3
• Security (0.94) 3
• Role (0.88) 2
• Enjoyment (0.63) 3
• Control (0.93) 1
• ICECAP Tariffs 0.61 (0.77)
EQ-5D+C
• Mobility (0.92) 2
• Self-Care (0.64) 3
• Usual activities (0.82) 3
• Pain/Discomfort (0.92) 1
• Anxiety/Depression (0.88) 1
• Cognition (0.64) 3
• EQ-5D+C Tariffs 0.66 (0.57)
ADRQL (Original weights)
• Social Interaction (SI) (22.69)
• Awareness of Self (AS) (17.36)
• Feelings and Mood (FM) (21.87)
• Enjoyment of Activities (EA) (31.58)
• Response to Surroundings (RS) (21.36)
• Overall ADRQL 73.39 (22.97)
Barthel-Index (ADL). Care level




The overall average scores for the instruments: average ICECAP-O score (based on the tariffs) was 0.61,
EQ-5D score was 0.66, and the ADRQL score (based on tariffs) was 73.39.
doi:10.1371/journal.pone.0169354.t002
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Discriminant Validity
In Table 4, the results of the ANOVA showed significant differences in ICECAP-O scores
between patients with different dementia severity and ages (i.e., above or below 75). ANOVA
results showed that the ICECAP-O tariff scores differentiated between residents classified into
different care dependency levels. As expected, lower scores were observed for the more severe
groups, and higher scores for the less severe groups.
Table 3. Convergent Validity.
ICECAP -O tariff ICECAP-O dimension scores
Attachment Security Role Enjoyment Control
Barthel-Index (ADL) Score 0.68** 0.25* 0.34* 0.72** 0.43** 0.86**
EQ-5D+C Utilities 0.62** 0.11* 0.32* 0.71** 0.56** 0.41**
EQ-5D+C Dimension Scores
• Mobility 0.59** 0.21 0.002 0.68* 0.47** 0.32*
• Self-Care 0.66* 0.34** -0.03 0.69* 0.37** 0.78**
• Usual Active 0.45** 0.69* 0.06 0.41** 0.27** 0.66**
• Pain/Discomfort 0.36* 0.21 -0.002 0.35** 0.42 0.65*
• Anxiety/ Depress 0.002 0.36** 0.14* 0.54 0.47** 0.004
• Cognition 0.54** 0.02 -0.05 0.36** 0.47** 0.35**
ADRQL Overall 0.61** 0.27* 0.23 0.45** 0.36 0.14**
ADRQL Dimension Scores
• Social Interaction (SI) 0.54** 0.65** 0.21 0.37 0.47* .046**
• Awareness of Self (AS) 0.02** 0.47** -0.03 0.36** 0.47* 0.25**
• Feelings and Mood (FM) 0.35* 0.54** 0.57** 0.28** 0.09 0.36*
• Enjoyment of Activities (EA) 0.23** 0.65* -0.21 0.03 0.38** 0.43**
• Response to Surroundings (RS) 0.21* 0.36* 0.55* 0.47** 0.26* 0.34**
*Significance on the 5% level;
**Significance on the 1% level.
doi:10.1371/journal.pone.0169354.t003
Table 4. Discriminant Validity.
Severity mildmean moderate severe p-value
mean (SD) mean (SD) mean (SD)
EQ-5D+C 0.71 (0.14) 0.62 (0.31) 0.31 (0.17) 0.000**
ICECAP-O 0.72 (0.11) 0.63 (0.21) 0.50 (0.10) 0.000**
ADRQL 77.02 (13.58) 73.21 (11.22) 62.74 (17.50) 0.000**
Age below 75 above 75 p-value
mean (SD) mean (SD)
EQ-5D+C 0.31 (0.17) 0.90 (0.21) 0.005**
ICECAP-O 0.59 (0.22) 0.84 (0.09) 0.000**
ADRQL 68.25 (17.52) 80.02 (16.21) 0.000**
Care level (ADL) low medium high p-value
mean (SD) mean (SD) mean (SD)
EQ-5D+C 0.74 (0.11) 0.60 (0.11) 0.32 (0.18) 0.000**
ICECAP-O 0.70 (0.19) 0.59 (0.14) 0.39 (0.12) 0.000**
ADRQL 74.11 (15.18) 71.45 (18.23) 59.77 (14.25) 0.000**
**Significance on the 1% level
doi:10.1371/journal.pone.0169354.t004
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Discussion
In this study, the ICECAP-O was used and validated for the first time in Spain in specialized
nursing homes for people with dementia. Our results indicated that the ICECAP-O has good
psychometric properties and convergent and discriminant validity.
Hypotheses were supported by the significant and strong correlations of the ICECAP-O tar-
iff scores with HRQoL scores (both EQ-5D+C and ADRQL scores) (H1) and with ADL scores
(H2). Moreover, as hypothesized (H3), the ICECAP-O significantly discriminated between
subgroups based on dementia severity (mild, moderate, and severe), ADL status (care levels of
low/middle/high) and age (residents <75 and >75 years), thus supporting discriminant valid-
ity. The results provide support that the ICECAP-O measures dimensions relevant for people
with dementia and therefore a broader spectrum than only health, as measured by the EQ-5D.
Methodological Limitations
This study has a number of limitations worth mentioning. First, the residents for this study
were not randomly selected and therefore might have characteristics that differ from the typi-
cal population with dementia in Spain nursing homes. However, this restriction may only
influence the results to a certain extent, because the focus of the study was the validation of the
properties of the quality of life measurement instruments and the current sample seems ade-
quate. Second, British tariffs were used for the ICECAP-O since Spanish tariffs are not yet
available. For this reason, results may be imprecise because weights for capability dimensions
might vary between countries.
Convergent Validity and Discriminant Validity
The average ICECAP-O tariff score found in this study within a nursing home setting (0.61)
was comparable to the scores reported in a Dutch study performed in nursing homes (0.63)
[28] and in a German study also performed in nursing homes (0.63) [30], and was substantially
lower than the score for community-living elderly, where the average scores ranged between
0.81–0.84 [22] [27] [31] [32] [37–41]. These findings support the reliability of our results.
The finding of the strong correlation between the ICECAP-O dimensions and the EQ-5D
dimensions shows that physical health is captured to a wide extent by the ICECAP-O capabil-
ity measurement, which is consistent with other findings [18] [28–32]. Overall, we found sig-
nificant correlations between the ICECAP-O dimensions and the individual EQ5D+C
dimensions, with the exception of attachment, which was not significantly correlated with the
mobility, pain/discomfort, and cognition dimensions of the EQ5D+C. Security was only sig-
nificantly correlated with the EQ5D dimension of anxiety/depression. This can be explained
because people with dementia, because the disease, lose their sense of security [41] [42].
Role and control correlated significantly with all EQ5D+C dimensions with the exception
of Anxiety/Depression, which could be because people with dementia, especially in moderate
and advanced stages, have anxiety disorders or depression treated with non-pharmacological
and pharmacological measures [43]. These findings are in line with other similar studies
[28–31]. The results confirmed the expected significant correlation between the ICECAP-O
and the ADRQL scores, which shows that the ICECAP-O captures both generic HRQoL and
dementia specific quality of life. The correlation between ADL and ICECAP-O scores reflected
that a loss of independence in ADL was associated with a decline in wellbeing. This correlation
is strengthened by the same finding for the other applied quality of life measurement instru-
ments in this study, confirming previous results that reduced ADL leads to a decrease in qual-
ity of life [44]. These significant findings point in the direction of favorable convergent
validity.
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The ICECAP-O dimension “security” is an exception to the other dimensions because it
showed almost no significant correlation with the majority of dimensions of the other quality
of life measures. The same finding was observed in the Dutch and German ICECAP-O valida-
tion studies in which no correlation with the dimension “security” was found [29, 30]. This
might be because people with dementia do not generally worry about the future past a certain
point, [41]. On the other hand, the moderately to highly significant correlations of the capabil-
ity dimensions “enjoyment,” “role,” and “control” with the ADRQL and the EQ-5D+C dimen-
sions support the hypothesis that the ICECAP-O captures dimensions that are relevant for the
elderly. Such correlations with the EQ-5D were also found in the general British population
[22] and in the German nursing homes [30] [41].
The ICECAP-O discriminated between patients based on the variables age, dementia sever-
ity, and ADL. Therefore, the group of healthier residents and the group with a higher func-
tional status also reached the expected higher tariff scores. This suggests that the ICECAP-O is
sensitive to age differences and to indicators of health, confirming that reasonable discrimi-
nant validity exists.
The ICECAP-O is a measure of wellbeing, and therefore has the potential to broaden the
evaluative space of economic evaluations in health care by focusing on more than health alone.
This is a particularly useful property in case populations such as institutionalized patients with
dementia, distinguished by decreasing independence and multi-morbidity, potentially across
different health dimensions.
Further research is needed to confirm the current favorable findings and to further explore
the feasibility, validity, and usefulness of the ICECAP-O instrument, as well as in the context
of economic evaluations. More research is especially encouraged in more homogeneous popu-
lations characterized by a single disease, since dementia is a syndrome with very heterogeneous
diseases (eg. Alzheimer, Lewy bodies, etc).
Conclusion
This study presented the first use of a Spanish version of the ICECAP-O. The results indicate
that the ICECAP-O appears to be a reliable wellbeing measurement instrument showing good
convergent and discriminant validity for people with dementia. The psychometric properties
are adequate, and we confirmed 5 dimensions and a good internal consistency of the question-
naire (Cronbach alpha = 0.820).
Future research is required to confirm these findings in other settings and similar samples,
with particular attention paid to dementia severity, diagnosis, and validation alongside demen-
tia specific quality of life measures.
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